Affordable Access

The metabolic syndrome: psychopharmacologists should weigh the evidence for weighing the patient.

Authors
Type
Published Article
Journal
The Journal of clinical psychiatry
Publication Date
Volume
63
Issue
12
Pages
1094–1095
Identifiers
PMID: 12523866
Source
Medline
License
Unknown

Abstract

We are in the midst of a North American epidemic of obesity and type 2 diabetes. Since patients with psychiatric disorders who receive psychopharmacologic treatments may be at even greater risk than the general population for weight gain, dyslipidemia, and diabetes and their complications, psychopharmacologists now need standards for how to monitor and manage these risks.

Statistics

Seen <100 times